(463 days)
This device is intended for aspiration biopsy in the biliary system.
The Howell Biliary Aspiration Needle is a sterile, single use device that consists of a luer slip handle with adjustment wheel, outer catheter sheath, needle catheter with needle, stylet and winged hub. The device is compatible with endoscopes with a minimum accessory channel of 2.8 mm. The Howell Biliary Aspiration Needle is 200 cm long. The catheter is comprised of PTFE while the needle is stainless steel and the stylet is nitinol.
The provided text describes a medical device submission (K153763) for the "Howell Biliary Aspiration Needle". This document is a 510(k) summary, which focuses on demonstrating substantial equivalence to a legally marketed predicate device rather than proving the safety and effectiveness of a novel device through extensive clinical trials for a new intended use.
Therefore, the document does not contain the information necessary to describe acceptance criteria and a study that proves a device meets those criteria in the context of an AI/ML or diagnostic imaging device, as implied by the structure of the prompt.
Specifically, the document states:
- "Performance testing consisting of non-clinical bench testing demonstrates that the Howell Biliary Aspiration Needle met the performance requirements to fulfill the intended use of the device."
- "The device is substantially equivalent to the cleared predicate device."
This indicates that the performance evaluation was based on bench testing for equivalence, not a clinical study designed to establish diagnostic performance against a ground truth.
Because the prompt asks for details typically found in submissions for AI/ML or diagnostic devices (e.g., sample size for test set, number of experts for ground truth, MRMC studies, standalone performance), and this document describes a physical medical instrument (a biopsy needle), most of the requested information is not applicable or present.
Therefore, I cannot populate the table or answer the specific questions as requested, because the provided text is about a physical medical device (a needle) and its substantial equivalence application, not a diagnostic or AI device with performance metrics like accuracy, sensitivity, or specificity against a ground truth from patient data.
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the top half of the circle. Inside the circle is an abstract symbol that resembles an eagle or a bird in flight, composed of three human profiles facing to the right.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
April 6, 2017
Wilson-Cook Medical, Inc. Ashley Howard Regulatory Affairs Specialist I 4900 Bethania Station Road Winston Salem, NC 27105
Re: K153763
Trade/Device Name: Howell Biliary Aspiration Needle Regulation Number: 21 CFR§ 876.1075 Regulation Name: Gastroenterology-Urology-Biopsy Instrument Regulatory Class: II Product Code: FCK Dated: April 3, 2017 Received: April 4, 2017
Dear Ashley Howard:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
{1}------------------------------------------------
You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely vours.
Image /page/1/Picture/8 description: The image shows the name "Charles Viviano -S" in a large, sans-serif font. The text is black against a white background. The text is horizontally oriented and centered in the image.
For Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known)
Device Name Howell Biliary Aspiration Needle
Indications for Use (Describe)
This device is intended for aspiration biopsy in the biliary system.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW .
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.
{3}------------------------------------------------
Image /page/3/Picture/0 description: The image shows the logo for Cook Medical. The logo is set against a red background. The word "COOK" is in white, and the registered trademark symbol is to the right of the word. Below the word "COOK" is the word "MEDICAL" in white.
COOK ENDOSCOPY 4900 bethania station road WINSTON-SALEM, NC 27105 U.S.A. PHONE: 336.744.0157 TOLL FREE: 800.245.4707 WWW.COOKMEDICAL.COM
6. 510 (k) Summary
| Name: | Wilson-Cook Medical, Inc. /Cook Endoscopy |
|---|---|
| Address: | 4900 Bethania Station Road |
| Winston-Salem, North Carolina 27105 | |
| Phone: | (336) 744-0157 |
| Fax: | (336) 201-5994 |
| Contact: | Ashley Howard, Regulatory Affairs Specialist I |
| Date: | December 30, 2015 |
| Trade Name: | Howell Biliary Aspiration Needle |
| Common Name: | Biliary Aspiration Needle |
| Classification Name: | Gastroenterology-Urology biopsy instrument (21 CFR 876.1075, Product |
| Code FCK) | |
| Legally MarketedDevices: | Wilson-Cook Biliary Aspiration Needle (K895900) |
| Description of theDevice: | The Howell Biliary Aspiration Needle is a sterile, single use device that |
| consists of a luer slip handle with adjustment wheel, outer catheter sheath, | |
| needle catheter with needle, stylet and winged hub. The device is | |
| compatible with endoscopes with a minimum accessory channel of | |
| 2.8 mm. The Howell Biliary Aspiration Needle is 200 cm long. The | |
| catheter is comprised of PTFE while the needle is stainless steel and thestylet is nitinol. | |
| Intended Use: | The Howell Biliary Aspiration Needle is used for aspiration biopsy in the |
| biliary system. | |
| TechnologicalCharacteristics: | The Howell Biliary Aspiration Needle has the same technological |
| characteristics as the Wilson-Cook Biliary Aspiration Needle (K895900) | |
| in terms of general design and function, but has minor differences in terms | |
| of handle mechanism and the addition of a stylet. | |
| Performance Data: | Performance testing consisting of non-clinical bench testing demonstrates |
| that the Howell Biliary Aspiration Needle met the performance | |
| requirements to fulfill the intended use of the device. The device is | |
| substantially equivalent to the cleared predicate device. |
§ 876.1075 Gastroenterology-urology biopsy instrument.
(a)
Identification. A gastroenterology-urology biopsy instrument is a device used to remove, by cutting or aspiration, a specimen of tissue for microscopic examination. This generic type of device includes the biopsy punch, gastrointestinal mechanical biopsy instrument, suction biopsy instrument, gastro-urology biopsy needle and needle set, and nonelectric biopsy forceps. This section does not apply to biopsy instruments that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification. (1) Class II (performance standards).(2) Class I for the biopsy forceps cover and the non-electric biopsy forceps. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.